Clinical Trial Update: Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

View source ↗

Summary

A completed clinical trial update discusses a non-invasive maternal plasma marker for screening fetal aneuploidies, including trisomies 21, 18, 13, and Turner s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome
• Edwards Syndrome
• Patau Syndrome
• Turner Syndrome

Snippet

Sponsor: Sequenom, Inc. | Conditions: Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18) | Status: COMPLETED